Optimal beam angle selection and knowledge-based planning significantly reduces radiotherapy dose to organs at risk for lung cancer patients

Lung cancer patients struggle with high toxicity rates. This study investigates if IMRT plans with individually set beam angles or uni-lateral VMAT plans results in dose reduction to OARs. We investigate if introduction of a RapidPlan model leads to reduced dose to OARs. Finally, the model is valida...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoffmann, Lone (VerfasserIn) , Knap, Marianne Marquard (VerfasserIn) , Alber, Markus (VerfasserIn) , Møller, Ditte Sloth (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Acta oncologica
Year: 2021, Jahrgang: 60, Heft: 3, Pages: 293-299
ISSN:1651-226X
DOI:10.1080/0284186X.2020.1856409
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/0284186X.2020.1856409
Volltext
Verfasserangaben:L. Hoffmann, M.M. Knap, M. Alber and D.S. Møller
Beschreibung
Zusammenfassung:Lung cancer patients struggle with high toxicity rates. This study investigates if IMRT plans with individually set beam angles or uni-lateral VMAT plans results in dose reduction to OARs. We investigate if introduction of a RapidPlan model leads to reduced dose to OARs. Finally, the model is validated prospectively. Seventy-four consecutive lung cancer patients treated with IMRT were included. For all patients, new IMRT plans were made by an experienced dose planner re-tuning beam angles aiming for minimized dose to the lungs and heart. Additionally, VMAT plans were made. The IMRT plans were selected as input for a RapidPlan model, which was used to generate 74 new IMRT plans. The new IMRT plans were used as input for a second RapidPlan model. This model was clinically implemented and used for generation of clinical treatment plans. Dosimetric parameters were compared using a Wilcoxon signed rank test or a 1-sided student’s t-test. p < .05 was considered significant. IMRT plans significantly reduced mean doses to lungs (MLD) and heart (MHD) by 1.6 Gy and 1.7 Gy in mean compared to VMAT plans. MLD was significantly (p < .001) reduced from 10.8 Gy to 9.4 Gy by using the second RapidPlan model. MHD was significantly (p < .001) reduced from 4.9 Gy to 3.9 Gy. The model was validated in prospectively collected treatment plans showing significantly lower MLD after the implementation of the second RapidPlan model. Introduction of RapidPlan and beam angles selected based on the target and OARs position reduces dose to OARs.
Beschreibung:Gesehen am 29.02.2024
Beschreibung:Online Resource
ISSN:1651-226X
DOI:10.1080/0284186X.2020.1856409